Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa

NCT00794586 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00794586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
March 31, 2010
Enrollment
120 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis